Hypermarcas (OTCMKTS:HYPMY) Trading 8.9% Higher – Should You Buy?

Hypermarcas (OTCMKTS:HYPMY) rose 8.9% during mid-day trading on Thursday . The stock traded as high as $4.67 and last traded at $4.67. Approximately 1,391 shares were traded during trading, a decline of 55% from the average daily volume of 3,110 shares. The stock had previously closed at $4.2896.

Hypermarcas Stock Up 8.9%

The company’s fifty day simple moving average is $4.51 and its 200 day simple moving average is $4.45. The company has a quick ratio of 0.84, a current ratio of 1.27 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $2.96 billion, a PE ratio of 20.30 and a beta of 0.72.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The firm had revenue of $408.83 million during the quarter.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.